Spots Global Cancer Trial Database for relative risk
Every month we try and update this database with for relative risk cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease | NCT02612350 | Mutation Neoplasms | ctDNA Analysis ... | 18 Years - | Pathway Genomics | |
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease | NCT02612350 | Mutation Neoplasms | ctDNA Analysis ... | 18 Years - | Pathway Genomics | |
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System | NCT00973362 | Human Papilloma... | APTIMA HPV Assa... FDA-Approved HP... | 21 Years - | Gen-Probe, Incorporated |